A Review on Novel Therapeutic Modalities and Evidence-based Drug Treatments Against Allergic Rhinitis
Curr Pharm Des. 2024 Mar 14. doi: 10.2174/0113816128295952240306072100. Online ahead of print.ABSTRACTAllergic rhinitis (AR) is an IgE-mediated atopic disease that occurs due to inhaled antigens in the immediate phase. Misdiagnosis, insufficient treatment, or no treatment at all are frequent problems associated with the widespread condition known as chronic allergic rhinitis. AR symptoms include runny, itchy, stuffy, and sneezing noses. Asthma and nasal polyps, for example, sometimes occur simultaneously in patients. In order for people living with AR to be as comfortable and productive as possible, treatment should center...
Source: Current Pharmaceutical Design - March 15, 2024 Category: Drugs & Pharmacology Authors: Bhupendra Sharma Rohitas Deshmukh Source Type: research
Baseline Severity and Disease Duration Can Predict the Response to Allergen-specific Immunotherapy in Allergic Rhinitis
Iran J Allergy Asthma Immunol. 2024 Feb 11;23(1):52-58. doi: 10.18502/ijaai.v23i1.14953.ABSTRACTAllergen-specific immunotherapy (AIT) has confirmed its efficacy in improving the symptoms of allergic rhinitis. However, no reliable biomarkers have been identified to predict the efficacy of AIT were found. We aimed to find clinical and immunological markers to predict efficacy in children after 2 years of sublingual immunotherapy (SLIT). A total of 285 children diagnosed with allergic rhinitis were recruited. The clinical efficacy was evaluated by comparing endpoint and baseline symptom and medication scores (SMS). Baseline c...
Source: Iranian Journal of Allergy, Asthma and Immunology - March 15, 2024 Category: Allergy & Immunology Authors: Yan Li Haiqing Xiao Yinhui Zeng Yiquan Tang Lifeng Zhou Wenlong Liu Source Type: research
A Review on Novel Therapeutic Modalities and Evidence-based Drug Treatments Against Allergic Rhinitis
Curr Pharm Des. 2024 Mar 14. doi: 10.2174/0113816128295952240306072100. Online ahead of print.ABSTRACTAllergic rhinitis (AR) is an IgE-mediated atopic disease that occurs due to inhaled antigens in the immediate phase. Misdiagnosis, insufficient treatment, or no treatment at all are frequent problems associated with the widespread condition known as chronic allergic rhinitis. AR symptoms include runny, itchy, stuffy, and sneezing noses. Asthma and nasal polyps, for example, sometimes occur simultaneously in patients. In order for people living with AR to be as comfortable and productive as possible, treatment should center...
Source: Current Pharmaceutical Design - March 15, 2024 Category: Drugs & Pharmacology Authors: Bhupendra Sharma Rohitas Deshmukh Source Type: research
Baseline Severity and Disease Duration Can Predict the Response to Allergen-specific Immunotherapy in Allergic Rhinitis
Iran J Allergy Asthma Immunol. 2024 Feb 11;23(1):52-58. doi: 10.18502/ijaai.v23i1.14953.ABSTRACTAllergen-specific immunotherapy (AIT) has confirmed its efficacy in improving the symptoms of allergic rhinitis. However, no reliable biomarkers have been identified to predict the efficacy of AIT were found. We aimed to find clinical and immunological markers to predict efficacy in children after 2 years of sublingual immunotherapy (SLIT). A total of 285 children diagnosed with allergic rhinitis were recruited. The clinical efficacy was evaluated by comparing endpoint and baseline symptom and medication scores (SMS). Baseline c...
Source: Iranian Journal of Allergy, Asthma and Immunology - March 15, 2024 Category: Allergy & Immunology Authors: Yan Li Haiqing Xiao Yinhui Zeng Yiquan Tang Lifeng Zhou Wenlong Liu Source Type: research
Baseline Severity and Disease Duration Can Predict the Response to Allergen-specific Immunotherapy in Allergic Rhinitis
Iran J Allergy Asthma Immunol. 2024 Feb 11;23(1):52-58. doi: 10.18502/ijaai.v23i1.14953.ABSTRACTAllergen-specific immunotherapy (AIT) has confirmed its efficacy in improving the symptoms of allergic rhinitis. However, no reliable biomarkers have been identified to predict the efficacy of AIT were found. We aimed to find clinical and immunological markers to predict efficacy in children after 2 years of sublingual immunotherapy (SLIT). A total of 285 children diagnosed with allergic rhinitis were recruited. The clinical efficacy was evaluated by comparing endpoint and baseline symptom and medication scores (SMS). Baseline c...
Source: Iranian Journal of Allergy, Asthma and Immunology - March 15, 2024 Category: Allergy & Immunology Authors: Yan Li Haiqing Xiao Yinhui Zeng Yiquan Tang Lifeng Zhou Wenlong Liu Source Type: research
Baseline Severity and Disease Duration Can Predict the Response to Allergen-specific Immunotherapy in Allergic Rhinitis
Iran J Allergy Asthma Immunol. 2024 Feb 11;23(1):52-58. doi: 10.18502/ijaai.v23i1.14953.ABSTRACTAllergen-specific immunotherapy (AIT) has confirmed its efficacy in improving the symptoms of allergic rhinitis. However, no reliable biomarkers have been identified to predict the efficacy of AIT were found. We aimed to find clinical and immunological markers to predict efficacy in children after 2 years of sublingual immunotherapy (SLIT). A total of 285 children diagnosed with allergic rhinitis were recruited. The clinical efficacy was evaluated by comparing endpoint and baseline symptom and medication scores (SMS). Baseline c...
Source: Iranian Journal of Allergy, Asthma and Immunology - March 15, 2024 Category: Allergy & Immunology Authors: Yan Li Haiqing Xiao Yinhui Zeng Yiquan Tang Lifeng Zhou Wenlong Liu Source Type: research
Baseline Severity and Disease Duration Can Predict the Response to Allergen-specific Immunotherapy in Allergic Rhinitis
Iran J Allergy Asthma Immunol. 2024 Feb 11;23(1):52-58. doi: 10.18502/ijaai.v23i1.14953.ABSTRACTAllergen-specific immunotherapy (AIT) has confirmed its efficacy in improving the symptoms of allergic rhinitis. However, no reliable biomarkers have been identified to predict the efficacy of AIT were found. We aimed to find clinical and immunological markers to predict efficacy in children after 2 years of sublingual immunotherapy (SLIT). A total of 285 children diagnosed with allergic rhinitis were recruited. The clinical efficacy was evaluated by comparing endpoint and baseline symptom and medication scores (SMS). Baseline c...
Source: Iranian Journal of Allergy, Asthma and Immunology - March 15, 2024 Category: Allergy & Immunology Authors: Yan Li Haiqing Xiao Yinhui Zeng Yiquan Tang Lifeng Zhou Wenlong Liu Source Type: research
Baseline Severity and Disease Duration Can Predict the Response to Allergen-specific Immunotherapy in Allergic Rhinitis
Iran J Allergy Asthma Immunol. 2024 Feb 11;23(1):52-58. doi: 10.18502/ijaai.v23i1.14953.ABSTRACTAllergen-specific immunotherapy (AIT) has confirmed its efficacy in improving the symptoms of allergic rhinitis. However, no reliable biomarkers have been identified to predict the efficacy of AIT were found. We aimed to find clinical and immunological markers to predict efficacy in children after 2 years of sublingual immunotherapy (SLIT). A total of 285 children diagnosed with allergic rhinitis were recruited. The clinical efficacy was evaluated by comparing endpoint and baseline symptom and medication scores (SMS). Baseline c...
Source: Iranian Journal of Allergy, Asthma and Immunology - March 15, 2024 Category: Allergy & Immunology Authors: Yan Li Haiqing Xiao Yinhui Zeng Yiquan Tang Lifeng Zhou Wenlong Liu Source Type: research
Baseline Severity and Disease Duration Can Predict the Response to Allergen-specific Immunotherapy in Allergic Rhinitis
Iran J Allergy Asthma Immunol. 2024 Feb 11;23(1):52-58. doi: 10.18502/ijaai.v23i1.14953.ABSTRACTAllergen-specific immunotherapy (AIT) has confirmed its efficacy in improving the symptoms of allergic rhinitis. However, no reliable biomarkers have been identified to predict the efficacy of AIT were found. We aimed to find clinical and immunological markers to predict efficacy in children after 2 years of sublingual immunotherapy (SLIT). A total of 285 children diagnosed with allergic rhinitis were recruited. The clinical efficacy was evaluated by comparing endpoint and baseline symptom and medication scores (SMS). Baseline c...
Source: Iranian Journal of Allergy, Asthma and Immunology - March 15, 2024 Category: Allergy & Immunology Authors: Yan Li Haiqing Xiao Yinhui Zeng Yiquan Tang Lifeng Zhou Wenlong Liu Source Type: research
Baseline Severity and Disease Duration Can Predict the Response to Allergen-specific Immunotherapy in Allergic Rhinitis
Iran J Allergy Asthma Immunol. 2024 Feb 11;23(1):52-58. doi: 10.18502/ijaai.v23i1.14953.ABSTRACTAllergen-specific immunotherapy (AIT) has confirmed its efficacy in improving the symptoms of allergic rhinitis. However, no reliable biomarkers have been identified to predict the efficacy of AIT were found. We aimed to find clinical and immunological markers to predict efficacy in children after 2 years of sublingual immunotherapy (SLIT). A total of 285 children diagnosed with allergic rhinitis were recruited. The clinical efficacy was evaluated by comparing endpoint and baseline symptom and medication scores (SMS). Baseline c...
Source: Iranian Journal of Allergy, Asthma and Immunology - March 15, 2024 Category: Allergy & Immunology Authors: Yan Li Haiqing Xiao Yinhui Zeng Yiquan Tang Lifeng Zhou Wenlong Liu Source Type: research
Baseline Severity and Disease Duration Can Predict the Response to Allergen-specific Immunotherapy in Allergic Rhinitis
Iran J Allergy Asthma Immunol. 2024 Feb 11;23(1):52-58. doi: 10.18502/ijaai.v23i1.14953.ABSTRACTAllergen-specific immunotherapy (AIT) has confirmed its efficacy in improving the symptoms of allergic rhinitis. However, no reliable biomarkers have been identified to predict the efficacy of AIT were found. We aimed to find clinical and immunological markers to predict efficacy in children after 2 years of sublingual immunotherapy (SLIT). A total of 285 children diagnosed with allergic rhinitis were recruited. The clinical efficacy was evaluated by comparing endpoint and baseline symptom and medication scores (SMS). Baseline c...
Source: Iranian Journal of Allergy, Asthma and Immunology - March 15, 2024 Category: Allergy & Immunology Authors: Yan Li Haiqing Xiao Yinhui Zeng Yiquan Tang Lifeng Zhou Wenlong Liu Source Type: research
Baseline Severity and Disease Duration Can Predict the Response to Allergen-specific Immunotherapy in Allergic Rhinitis
Iran J Allergy Asthma Immunol. 2024 Feb 11;23(1):52-58. doi: 10.18502/ijaai.v23i1.14953.ABSTRACTAllergen-specific immunotherapy (AIT) has confirmed its efficacy in improving the symptoms of allergic rhinitis. However, no reliable biomarkers have been identified to predict the efficacy of AIT were found. We aimed to find clinical and immunological markers to predict efficacy in children after 2 years of sublingual immunotherapy (SLIT). A total of 285 children diagnosed with allergic rhinitis were recruited. The clinical efficacy was evaluated by comparing endpoint and baseline symptom and medication scores (SMS). Baseline c...
Source: Iranian Journal of Allergy, Asthma and Immunology - March 15, 2024 Category: Allergy & Immunology Authors: Yan Li Haiqing Xiao Yinhui Zeng Yiquan Tang Lifeng Zhou Wenlong Liu Source Type: research
Baseline Severity and Disease Duration Can Predict the Response to Allergen-specific Immunotherapy in Allergic Rhinitis
Iran J Allergy Asthma Immunol. 2024 Feb 11;23(1):52-58. doi: 10.18502/ijaai.v23i1.14953.ABSTRACTAllergen-specific immunotherapy (AIT) has confirmed its efficacy in improving the symptoms of allergic rhinitis. However, no reliable biomarkers have been identified to predict the efficacy of AIT were found. We aimed to find clinical and immunological markers to predict efficacy in children after 2 years of sublingual immunotherapy (SLIT). A total of 285 children diagnosed with allergic rhinitis were recruited. The clinical efficacy was evaluated by comparing endpoint and baseline symptom and medication scores (SMS). Baseline c...
Source: Iranian Journal of Allergy, Asthma and Immunology - March 15, 2024 Category: Allergy & Immunology Authors: Yan Li Haiqing Xiao Yinhui Zeng Yiquan Tang Lifeng Zhou Wenlong Liu Source Type: research
Baseline Severity and Disease Duration Can Predict the Response to Allergen-specific Immunotherapy in Allergic Rhinitis
Iran J Allergy Asthma Immunol. 2024 Feb 11;23(1):52-58. doi: 10.18502/ijaai.v23i1.14953.ABSTRACTAllergen-specific immunotherapy (AIT) has confirmed its efficacy in improving the symptoms of allergic rhinitis. However, no reliable biomarkers have been identified to predict the efficacy of AIT were found. We aimed to find clinical and immunological markers to predict efficacy in children after 2 years of sublingual immunotherapy (SLIT). A total of 285 children diagnosed with allergic rhinitis were recruited. The clinical efficacy was evaluated by comparing endpoint and baseline symptom and medication scores (SMS). Baseline c...
Source: Iranian Journal of Allergy, Asthma and Immunology - March 15, 2024 Category: Allergy & Immunology Authors: Yan Li Haiqing Xiao Yinhui Zeng Yiquan Tang Lifeng Zhou Wenlong Liu Source Type: research
Baseline Severity and Disease Duration Can Predict the Response to Allergen-specific Immunotherapy in Allergic Rhinitis
Iran J Allergy Asthma Immunol. 2024 Feb 11;23(1):52-58. doi: 10.18502/ijaai.v23i1.14953.ABSTRACTAllergen-specific immunotherapy (AIT) has confirmed its efficacy in improving the symptoms of allergic rhinitis. However, no reliable biomarkers have been identified to predict the efficacy of AIT were found. We aimed to find clinical and immunological markers to predict efficacy in children after 2 years of sublingual immunotherapy (SLIT). A total of 285 children diagnosed with allergic rhinitis were recruited. The clinical efficacy was evaluated by comparing endpoint and baseline symptom and medication scores (SMS). Baseline c...
Source: Iranian Journal of Allergy, Asthma and Immunology - March 15, 2024 Category: Allergy & Immunology Authors: Yan Li Haiqing Xiao Yinhui Zeng Yiquan Tang Lifeng Zhou Wenlong Liu Source Type: research
